EUCTR2005-004942-15-IT
Active, not recruiting
Not Applicable
A prospective, randomized, multi-center comparative 2-arm trial on efficacy and safety of zoledronic acid every 3-months vs. every 4 weeks beyond approximately 1 year of treatment with zoledronic acid in patients with bone lesions from breast cancer - ND
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- OVARTIS FARMA
- Enrollment
- 420
- Status
- Active, not recruiting
- Last Updated
- 14 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Female patients 18 years of age. Written informed consent given. Histologically confirmed Stage IV breast cancer with at least one bone metastasis radiologically confirmed. Life expectancy 1 year. Treatment with Zometa every 3\-4 weeks, for 9\-12 infusions over no more than 15 months. ECOG performance status 2\.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) yes
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •More than 3 months since last infusion of Zometa. Treatments with other bisphosponates than Zometa at any time prior to study entry. Serum creatinine 3 mg/dL 265 mol/L or calculated Cockcroft\-Gault formula creatinine clearance CLCr 30 mL/min CrCl 140\-age years x weight kg x 0\.85 72 x serum creatinine mg/dL Corrected adjusted for serum albumin serum calcium 8 mg/dl 2 mmol/L or 12 mg/dL 3\.0 mmol/L . Current active dental problem including infection of the teeth or jawbone maxilla or mandibular ; dental or fixture trauma, or a recurrent or prior diagnosis of osteonecrosis of the jaw ONJ , of exposed bone in the mouth, or of slow healing after dental procedures. Recent within 6 weeks or planned dental or jaw surgery e.g. extraction, implants . Pregnant patients with a positive pregnancy test prior to study entry or lactating patients. Women of childbearing potential not using effective methods of birth control e.g. abstinence, oral contraceptives or implants, IUD, vaginal diaphragm or sponge, or condom with spermicide . History of non\-compliance to medical regimens or potential unreliable behavior. Known sensitivity to study drug s or class of study drug s . Patients with severe medical condition s that in the view of the investigator prohibits participation in the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Clinical study on AP/VJT/SBO Ayurvedic Hair Oil in femalesHealth Condition 1: L658- Other specified nonscarring hair lossCTRI/2022/05/042393AYURVED PRATISTHA
Completed
Phase 4
A prospective, multi-centre randomised comparative study ofimplant fit, clinical outcomes and satisfaction with the Stryker Accolade II Hip Stem compared to the Corail Hip StemTotal Hip Replacement SurgeryNon-Inflammatory Degenerative Joint Disease of the HipMusculoskeletal - Other muscular and skeletal disordersACTRN12613000629730Stryker Australia Pty Ltd304
Not yet recruiting
Phase 4
A comparative, multicenter, prospective, randomized study to evaluate efficacy, safety and prevention of relapse with Elovera AD emollient vs plain emollient in mild to moderate atopic dermatitisHealth Condition 1: L209- Atopic dermatitis, unspecifiedCTRI/2023/03/050333Glenmark Pharmaceuticals Limited
Not yet recruiting
Not Applicable
A Multi-center, Prospective, Randomized Comparison of Pulmonary Vein Isolation Techniques in Patients with Paroxysmal Atrial FibrillatioDiseases of the circulatory systemKCT0000329Asan Medical Center100
Recruiting
Not Applicable
A multicenter, prospective, comparative, randomized, independent rater-blind, superiority, pivotal clinical trial to compare the safety and efficacy of the Cognitive therapy software ‘SUPERBRAIN DEX’ for improving cognitive function with a control group for patients with mild cognitive impairmentMental and behavioural disordersKCT0009133Hanyang University Guri Hospital126